CrossRef Hepatic Metabolic Signature and Its Association with the Response to Immunotherapy in Hepatocellular Carcinoma Hyewon Park, Sowon Park, Kena Park, Sun Young Yim, Ju-Seog Lee, Sung Hwan Lee ImmunoTargets and Therapy .2025
Still, there is no universal day when side effects begin or a guarantee that they disappear by month 3
Consult an immunologist before starting
Shima Hadidchi MD Family Practice, we are committed to offering comprehensive, evidence-based care for patients struggling with obesity and related health conditions
The only thing to be aware of is that the first month is heavily discounted, so your second month and beyond will be more costly
As of 2026, retatrutide is not FDA-approved for any indication